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Tethering of vesicles to the Golgi by GMAP210
controls LAT delivery to the immune synapse
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The T cell immune synapse is a site of intense vesicular trafﬁcking. Here we show that the
golgin GMAP210, known to capture vesicles and organize membrane trafﬁc at the Golgi, is
involved in the vesicular transport of LAT to the immune synapse. Upon activation, more
GMAP210 interact with LAT-containing vesicles and go together with LAT to the immune
synapse. Regulating LAT recruitment and LAT-dependent signaling, GMAP210 controls T cell
activation. Using a rerouting and capture assay, we show that GMAP210 captures VAMP7-
decorated vesicles. Overexpressing different domains of GMAP210, we also show that
GMAP210 allows their speciﬁc delivery to the immune synapse by tethering LAT-vesicles to
the Golgi. Finally, in a model of ectopic expression of LAT in ciliated cells, we show that
GMAP210 tethering activity controls the delivery of LAT to the cilium. Hence, our results
reveal a function for the golgin GMAP210 conveying speciﬁc vesicles to the immune synapse.
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ommunication of cells with their extracellular environ-
ment is a critical function for all eukaryotic cells. It is
particularly important for the cells of the immune system
that have to “sense” the danger in a full organism. This is
probably why T lymphocytes have evolved to form a structure,
specialized in cell–cell communication, which is generated upon
direct contact between T lymphocytes and antigen-presenting
cells and called the immune synapse1,2.
The immune synapse is a place of intense vesicular endocytic
and exocytic trafﬁc that control many aspects of T cell activities
and functions. Indeed, the polarized release, at the immune
synapse, of cytokines3,4, extracellular vesicles5–7, and receptors
and ligands such as CD40L8,9, regulates their communication
with the interacting cells and environment. It also shapes the
adaptive immune response. This endocytic and exocytic trafﬁc of
vesicular compartments has also been shown to regulate TCR-
induced signaling10. Recent results including ours have shown
that molecules and enzymes, involved in signaling in T lym-
phocytes, are present both at the plasma membrane and in
intracellular vesicular pools11–17. Remarkably different signaling
mediators are present in different vesicles associated to a unique
set of trafﬁc regulators and effectors, such as Rab GTPase and v-
SNARE proteins10,18. Hence different signaling molecules follow
different endocytic and exocytic pathways. This may control the
physical separation of signaling molecules in distinct modules
that can be assembled in response to speciﬁc triggering19. These
results also raise the question of the nature of the different
vesicles, the control of their localization and of their polarized
delivery to the immune synapse. We previously showed that
trafﬁcking to the immune synapse of the Linker for activation of
T cells (LAT), a transmembrane protein that plays a key role in T
lymphocyte signaling and function20–23, is regulated by the
vesicular SNARE VAMP713. We also recently found that the
plasma membrane pool of LAT, after its TCR-induced inter-
nalization, is following the canonical retrograde Rab6/syntaxin 16
pathway to the Golgi before being transported back to the
immune synapse24. This retrograde vesicular trafﬁcking of LAT
controls the formation of signaling complexes13,24,25, also known
as signalosomes and regulates some aspects of T cell activation.
Yet, the spatial organization of this trafﬁc is not known. We
describe herein a new mechanism by which a golgin, speciﬁcally
conveys LAT-containing vesicles to the immune synapse.
Golgins are long coiled–coiled proteins attached to the Golgi
membrane via their C-terminal part, which can “capture” vesicles
at long distance through their N-terminal motifs increasing the
efﬁciency of trafﬁcking26,27. They have been proposed to ensure
the speciﬁc delivery of vesicles containing given cargoes to the
right membrane destination in the cells26–29. GMAP210 is one of
these golgins. It anchors at the cis-Golgi via the interaction of its
C-terminal GRAB (GRIP-related Arf binding) domain with
Arf130–32. It captures vesicles through its N-terminal domain31,
which contains a curvature-sensing amphipathic lipid-packing
sensor (ALPS) motif that binds liposomes of high membrane
curvature (radius < 50 nm)33 and of particular lipid composition
and packing34. GMAP210 has been involved in trafﬁcking of
Golgi resident membrane proteins and of ER to Golgi markers28.
It has also been shown to bind the intraﬂagellar protein
IFT2035,36 and controls trafﬁcking of some cargos to the primary
cilium and signaling by this structure35,37,38.
Here we identify the golgin GMAP210 as a speciﬁc binder of
vesicles containing LAT/VAMP7. We show that it controls the
polarized recruitment of LAT at the immune synapse, the for-
mation of the LAT signalosome, and the TCR-induced activation
of T lymphocytes. Our results reveal a mechanism that controls
the correct localization of LAT to the immune synapse by
tethering the VAMP7/LAT-positive vesicles to the Golgi. Hence
our results reveal how the unique capacities of the golgin
GMAP210 to capture and tether membranes are being used by
T cells to selectively sort and deliver vesicles in the crowded
environment of the immune synapse.
Results
Presence of GMAP210 in LAT-containing membranes. We
have previously shown that LAT is present in vesicles that are
recruited to the immune synapse13. To better characterize the
content of these vesicles as well as their mechanisms of transport,
we puriﬁed the vesicles containing LAT and performed a pro-
teomic analysis of their content using a method we set up in the
laboratory39. After mechanical disruption of LAT-deﬁcient Jurkat
T cells (JCAM-2.5)40 expressing the chimeric LAT-twin-Strep-
Tag (LAT-TST)25, membranes were submitted to a ﬂoatation
gradient. Fractions were recovered from top (fraction 1) to bot-
tom (fraction 10). Fraction 3, which was enriched in both LAT
and the v-SNARE VAMP7 involved in LAT trafﬁcking13
(Fig. 1a), was submitted to pull down with Strep-Tactin Sephar-
ose. The proteomic analysis of the puriﬁed material revealed the
presence of the golgin GMAP210. Electron microscopy of fraction
3 conﬁrmed the presence of GMAP210 and LAT on the same
membranes (Fig. 1b). Western blot analysis performed on
membranes from fraction 3 puriﬁed with Strep-Tactin Sepharose,
conﬁrmed the proteomic analysis. It showed an enrichment of
GMAP210 in membranes from JCAM-2.5 expressing LAT-TST
as compared to the control cells, whereas GMAP210 was present
at the same level in fraction 3 and lysates of both cell types
(Fig. 1c). GM130, another cis-golgin expressed by the cells
(presence in the fraction 3 and whole lysates, Fig. 1c) was less
present in the pull down (Fig. 1c), showing the speciﬁcity of the
presence of GMAP210 together with LAT. Of note, VAMP7 was
also enriched in the membranes puriﬁed from JCAM-2.5 cells
expressing LAT-TST (Fig. 1c) conﬁrming the presence of this
vesicular SNARE on LAT-containing membranes13. Thus,
GMAP210 is present together with LAT on intracellular mem-
branes. This was surprising since GMAP210 was known to be
present on the cis-Golgi, whereas the intracellular pool of LAT
was mainly present in recycling compartments11,15. Electron
microscopy performed on T cells showed that at steady state
some LAT and GMAP210 were found together in small vesicles
with a diameter inferior to 100 nm, located in the vicinity of the
Golgi apparatus (Fig. 1d, red arrows). LAT and GMAP210 were
also present together on the membrane of larger electron-
translucent vesicles that seemed to “cap” one of the centrosomes
(Fig. 1d, blue arrows) resembling the primary ciliary vesicle41.
Our confocal microscopy analysis conﬁrmed that in T lympho-
cytes, like in other cell types31,42, GMAP210 co-localized with
GM130 and CTR-433 two markers of the cis-medial-Golgi but
little with the Trans-Golgi network marker TGN-46 (supple-
mentary Fig. 1).
GMAP210 is recruited together with LAT to the immune
synapse. Previous results were obtained at steady state. We asked
whether activation of T cells would regulate the presence of
GMAP210 on LAT-containing vesicles. Fractionation experi-
ments described above were performed on Jurkat T cells acti-
vated, for several times with anti-CD3+ anti-CD28. We ﬁrst
noticed that T cell activation induced GMAP210 enrichment in
fraction 3 as compared to resting T cells (Fig. 2a). This was
accompanied by a three-fold increase in the presence of
GMAP210 on the LAT-TST-containing vesicles puriﬁed with
streptactin (Fig. 2a). These results show that T cell activation
induces the recruitment of GMAP210 on LAT-containing vesi-
cles. They correlated with confocal images realized on conjugates
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Fig. 1 GMAP210 is present in membranes puriﬁed from T lymphocytes and containing LAT. a JCAM2.5 LAT-deﬁcient T-cells expressing a chimeric mouse
LAT coupled to two Strep-Tag (LAT-TST) were mechanically disrupted. The membrane fraction was then submitted to a ﬂoatation gradient on iodixanol.
After ultracentrifugation, 10 fractions from top to bottom were collected and submitted to SDS–PAGE and Western blot analysis. b Transmission electron
microscopy performed on membranes from fraction 3 showing an immunogold staining for LAT (6 nm gold particles) and GMAP210 (10 nm gold particles).
Scale bar: 50 nm. c Fraction 3 prepared from JCAM2.5 (JCAM) or JCAM2.5 expressing LAT-TST (LAT-TST) were prepared as in a. They were mixed with
Strep-Tactin Sepharose and submitted to SDS–PAGE and Western blot analysis. The presence of GMAP210, GM130, LAT-TST, and VAMP7 in: the fraction
3 before precipitation; the Strep-Tactin precipitates (StepTactin); and the total lysates obtained in the presence of detergent (Lysate), are shown. Ratios
showing the relative expression of the different proteins in JCAM2.5 expressing LAT-TST as compared to the expression in JCAM2.5 are presented under
each WB (LAT-TST/JCAM). d Transmission electron microscopy images of ﬁxed Jurkat cells overexpressing LAT showing an immunogold staining for LAT
(6 nm gold particles) and GMAP210 (10 nm gold particles); c centriole; g Golgi apparatus. Red arrows show small vesicles presenting both LAT and
GMAP210 staining, blue arrows show a bigger vesicle “capping” a centriole. White Scale bar: 1 μm, gray scale bar: 500 nm, black scale bar: 200 nm. Data
represent three independent experiments (a) and one experiment (b–d)
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between Jurkat T cells and Raji B cells used as antigen-presenting
cells (APC). Indeed, at steady state, i.e. in the absence of SEE, the
intracellular pool of LAT showed only inconspicuous colocali-
zation with GMAP210. Activation with SEE induced the rapid
recruitment of LAT at the immune synapse, which was accom-
panied in the ﬁrst 15 min by a polarization of GMAP210 toward
the synapse and an intertwined localization of both molecules
(Fig. 2b and quantiﬁed in Fig. 2c). At 30 min GMAP210 was
slightly behind the immune synapse. In these conditions, as
reported by others43,44, we often observed the rims of the Golgi
stacks, labeled with GMAP210, in close proximity to the area of
the immune synapse where LAT was enriched (Fig. 2b). To study
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more precisely if GMAP210 was recruited to the synaptic zone
together with LAT, we performed total internal reﬂection ﬂuor-
escence microscopy (TIRFM) in T cells expressing GMAP210-
GFP. Cells were seeded on activating coverslips coated with anti-
CD3 and anti-CD28 mAbs, to mimic immune synapse formation,
or with poly-L-Lysine as control (Fig. 2d). Quantiﬁcation of the
TIRFM images, performed 10 min after seeding, revealed
“punctae” of GMAP210 that can be observed in activating con-
ditions (Fig. 2d, upper panel and quantiﬁcation on the right).
These “punctae” were revealed by TIRFM, showing that they were
present in a 200–300 nm of the contact zone. The density of
GMAP210 and LAT punctae were very similar (Fig. 2d, quanti-
ﬁcation) and GMAP210 and LAT co-localized strongly (Fig. 2e,
quantiﬁcation). Of note, images were taken 10 min after inter-
action with the activating slide, at a time point shown by others to
correspond to a recruitment of abundant vesicles45. Because
GMAP210 was never observed in the plasma membrane, our
results suggest that the punctae revealed by TIRFM correspond to
vesicular pool of LAT coming together with GMAP210 in the
synaptic zone (Fig. 2d). The co-localization of LAT with
GMAP210 was not due to the mere recruitment of the Golgi
apparatus to the immune synapse, since neither the cis-golgin
GM130 (Fig. 2d, lower panel, co-localization quantiﬁed in 2e),
nor the medial-Golgi marker CTR43346 (Supplementary Fig. 2a
and quantiﬁed in Ssupplementary Fig. 2b) co-localized with LAT
at the immune synapse. This was not an artifact of overexpression
of GMAP210-GFP, since colocalization of LAT with endogeneous
GMAP210 was also observed (Supplementary Fig. 2a, lower
panels and quantiﬁcation of colocalization Supplementary
Fig. 2b). Live video microscopy of T cells expressing both LAT-
mCherry and GMAP210-GFP seeded on activating coverslips
showed that LAT and GMAP210 arrived at the same time in the
evanescent ﬁeld. They also moved together suggesting that
GMAP210, which is not present at the plasma membrane, is
associated with the vesicular pool of LAT and recruited to the
inner face of the IS (Fig. 2f, Supplementary Movie 1). We have
previously shown that the vesicular pool of LAT contributes to
the formation of a signalosome47, which is assembled upon TCR
triggering13. We reasoned that if GMAP210 is recruited together
with LAT at the immune synapse, it might be part of this sig-
nalosome. To test this hypothesis, we activated T cells with
magnetic beads coated with anti-CD3+CD28 mAb, retained the
bead-cell conjugates on a magnet and subjected them to cycles of
freezing and thawing. Western blot analysis of the bead-
associated complexes revealed the presence of LAT, as well as
different signaling molecules: the adaptor SLP76, the tyrosine
kinase p56lck and the phospholipase PLCγ1 (Fig. 2f), which play
a role in T cell activation. It also revealed the progressive
recruitment of GMAP210 with the same kinetic as VAMP7
(Fig. 2g). The absence of GM130 from this signalosome
demonstrated that the presence of GMAP210 was not due to a
mere contamination by material from the Golgi apparatus.
Altogether these results suggest that TCR activation induces
the rapid recruitment of GMAP210 on vesicles containing LAT
and suggest a role for GMAP210 in the delivery of the vesicular
pool of LAT.
GMAP210 controls the delivery of LAT to the immune
synapse. To test whether GMAP210 was involved in the
recruitment of the vesicular pool of LAT to the immune synapse,
we silenced GMAP210 in Jurkat T cells or human primary CD4+
-activated T cells using lentivirus encoding either of two different
short hairpin RNAs (shRNAs) targeting GMAP210 (Sh3 or Sh8).
In both Jurkat and primary T cells, GMAP210 protein expression
was decreased to 40% of the control cells (Supplementary Fig. 3a
for Jurkat and Supplementary Fig. 3c for primary T cells). We
controlled the expression at the plasma membrane of different
key markers of T cells, such as CD3, CD28, TCR, CD4, and
CD45, which was not affected by GMAP210 silencing (Supple-
mentary Fig. 3b for Jurkat and Supplementary Fig. 3d for primary
T cells) showing that GMAP210 silencing did not grossly affect
secretion at the plasma membrane in T cells. Besides,
GMAP210 silencing did not affect the expression of LAT in
T cells. Indeed, silenced T cells expressed the same amount of
LAT (Supplementary Fig. 3b for Jurkat and Supplementary Fig.
3d for primary T cells). Moreover, at steady state, expression of
LAT at the plasma membrane, as measured by FACS on T cells
expressing a chimeric LAT tagged with HA in its N-term extra-
cellular region (HA-LAT)13,24 was not affected either (Supple-
mentary Fig. 3b). We then quantiﬁed the recruitment of LAT to
the immune synapse. To do so we ﬁrst quantiﬁed LAT enrich-
ment at the immune synapse in Jurkat T cells interacting with
Raji B cells in the absence of SEE (no synapse formation) or
presence of SEE (formation of the immune synapse) (average
density map representation in a “mean cell” Fig. 3a and Supple-
mentary Fig. 4a, and quantiﬁcation in Figs. 3b and 4b). We also
quantiﬁed on TIRFM images the number of LAT punctae in the
synaptic area in Jurkat T cells or CD4+ human primary T cell
blasts 10 min after seeding on activating slides (Fig. 3e, f for
Jurkat and Supplementary Fig. 4c: quantiﬁcation in primary
T cells). In both models, LAT recruitment was decreased when
GMAP210 was silenced (quantiﬁcation Fig. 3b, d and
Fig. 2 GMAP210 is recruited together with LAT at the immune synapse. a JCAM2.5 LAT-deﬁcient T-cells expressing LAT-TST were activated for different
time with anti-CD3ε+antiCD28, mechanically disrupted and membrane fractions were puriﬁed. Presence of GMAP210 and LAT-TST in fraction 3 and in
precipitates (StepTactin), are shown. LAT-TST and GMAP210 intensities were quantiﬁed and expressed as fold increase of time 0. b Confocal images
performed on Jurkat T-Raji conjugates (in blue) and pulsed with SEE for 0, 5, 10, 15 and 30min, showing the relative localization of LAT and GMAP210.
Images show the maximum intensity from z-projections of three–four z-stacks covering the GMAP210 staining. White scale bars: 5 μm, gray scale bars:
500 nm. c Quantiﬁcation of GMAP210/LAT colocalization. Each dot= one cell; horizontal lines=median. *P < 0.05, ****P < 0.0001, ns= non-signiﬁcant
(one-way ANOVA). d TIRFM images of Jurkat cells incubated for 10min on coverslips coated with anti-CD3ε+anti-CD28, before ﬁxation and staining
for LAT, GMAP210-GFP, or GM130, scale bars: 5 μm. Dot plots show the quantiﬁcation of the number of punctas/µm2 formed by the different molecules
in the evanescent ﬁeld (right). Poly-L-Lysine (Poly-Lys) alone (resting conditions) or anti-CD3/CD28 (α-CD3ε α-CD28) immune synapse formation.
e Quantiﬁcation of the colocalization of LAT with GMAP210 or GM130. Each dot= one cell; horizontal lines=median. ****P < 0.0001, ns: non-signiﬁcant
(one-way ANOVA). f Live TIRF imaging of the recruitment of LAT and GMAP210 at the immune synapse. Jurkat cells co-expressing GMAP210-GFP and
LAT-mCherry were seeded on coverslips coated with anti-CD3ε+antiCD28. White squares indicate the magniﬁed regions presented underneath that show
the simultaneous appearance and displacement of LAT and GMAP210 in the evanescent ﬁeld. White scale bars: 5 μm, gray scale bars: 2 μm. f Immunoblot
of signalosomes prepared from Jurkat cells activated for 0, 5, 10 or 15 min with magnetic beads coated with mAb to CD3 and to CD28 (above blots).
Proteins attached to the beads were puriﬁed by magnetic sorting after freezing and thawing of the cells. Presence of the different proteins in the
corresponding cell lysates (with detergent) are shown in “input” lanes. Dashed line indicates a separate experiment. Data represent more than three
experiments (g), two experiments (f), and one experiment (a–e)
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Supplementary Fig. 4c). This defect in LAT recruitment at the
immune synapse led to a decreased phosphorylation of LAT (Tyr-
191) observed in conjugates (Fig. 3c representative images,
quantiﬁcation in Fig. 3d) and by TIRFM (for Jurkat Fig. 3e
quantiﬁed in Fig. 3f; for primary T cells quantiﬁcation in Sup-
plementary Fig. 4c). These results suggested that the pool of LAT
that is recruited in a GMAP210-dependent manner is phos-
phorylated. In contrast, recruitment of other signaling molecules,
such as CD3-ζ, the phosphorylated form of ZAP70 (Fig. 3c–f for
Jurkat T cells, Supplementary Fig. 4c for primary T cells) and the
TCR (Supplementary Fig. 4a and 4b), which like LAT are
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Fig. 3 GMAP210 expression controls formation of the immune synapse. a, b Confocal images a and quantiﬁcation b of the enrichment of LAT (left pannel)
and CD3ζ-GFP (rigth pannel) at the immune synapse (depicted by the dotted white line) in Jurkat “mean cells” expressing non-targeting control ShRNA c
or GMAP210-targeting ShRNA (3 and 8) and interacting for 30min with Raji cells left unpulsed (−, unactivated state) or pulsed with SEE (+, immune
synapse formation). N= number of cells constituting the mean image. Horizontal lines represent median. c and d Confocal images of conjugates of Jurkat
cells expressing control (C) or GMAP210-speciﬁc shRNA (3 and 8) and SEE-pulsed Raji B cells (blue) labeled with anti-phospho LAT (P-LAT, showed in
green, left pannel) or anti-phospho-ZAP70 (P-ZAP, showed in green, right pannel) and anti-GMAP210 (red) antibodies, assessed at 30min c, and
quantiﬁcation d of the mean ﬂuorescence intensity of P-LLAT and P-ZAP70, assessed in a ﬁxed region of the immunimmune synapse and divided by the
average of the mean intensities measured in three regions of the same size at the plasma membrane outside of the IS. Horizontal lines represent median.
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enriched at the IS upon T-cell activation, was not affected by
silencing of GMAP210.
These results demonstrate that GMAP210 is involved in the
recruitment of the vesicular pool of LAT to the immune synapse
but that it does not participate in the recruitment of CD3-ζ.
GMAP210 controls signalosome formation and T-cell func-
tion. Others and us have shown that the recruitment of the
vesicular pool of LAT is involved in T-cell activation13–16,24. We
reasoned that GMAP210 by altering LAT recruitment to the IS
should also control the activation of T lymphocytes. We activated
GMAP210-silenced T cells with activating magnetic beads and
puriﬁed the membranes associated with the beads as before
(Fig. 2g) to study the composition of the signalosome. T cells
transfected with control shRNA showed enrichment, in the sig-
nalosome, of LAT, PLCγ1, and SLP-76, as well as the vesicular
SNARE VAMP7 (Fig. 4a). Of note, Western blot analysis of
VAMP7 in the signalosome showed two bands. These two bands
were observed in the signalosome shown in Fig. 2g and in the
LAT-containing puriﬁed vesicles (Fig. 1c) but only one band was
observed in the total cell lysates (“lysate” Fig. 1c, “input” Figs. 2g
and 4a). This might reﬂect the enrichment in LAT-containing
vesicles and in the signalosome of a pool of VAMP7 presenting
post-translational modiﬁcations that modify its apparent mole-
cular weight. In GMAP210-silenced cells the signaling complexes
were incomplete. They contained less LAT, and SLP76 and
almost no PLCγ1 (Fig. 4a and quantiﬁed in Fig. 4b) demon-
strating the role played by GMAP210 in the formation of this
signalosome. Moreover, they contain less VAMP7 suggesting a
defect in the recruitment of VAMP7-bearing vesicles. In contrast,
GMAP210 silencing did not alter the presence of CD3-ζ in the
signalosomes (Fig. 4a), conﬁrming the TIRF and confocal
microscopy results, which showed normal recruitment of CD3-ζ
to the synapse (Fig. 3). Activation of helper T lymphocytes by the
TCR is characterized by the production of cytokines. To test if
GMAP210 is indeed involved in T cell activation, we activated
Jurkat T cells with APC or human CD4+ T lymphoblasts with
different concentrations of anti-CD3 Abs and measured the
production of cytokines (IL-2 for Jurkat and IFN-γ for primary
T cells). Silencing of GMAP210 decreased the production of
cytokines induced by TCR triggering at the protein (Fig. 4c:
Jurkat and Fig. 4e: primary T cells) and mRNA level (Fig. 4d:
Jurkat T cells). In contrast, GMAP210 silencing did not affect
cytokine production induced by the PMA plus ionomycin (Fig. 4f,
primary T cells) combination of pharmaceutical agents known to
bypass LAT signaling40. These last results show that decrease of
TCR-induced cytokine secretion by GMAP210 silencing is not
due to a general effect on cytokine secretion but rather due to a
defect in early TCR signaling. Altogether, these results show that
GMAP210 is required for the formation of a functional TCR-
induced signalosome and for T-cell function.
GMAP210 captures vesicles carrying the VAMP7 vesicular
SNARE. We have previously shown that the vesicular SNARE
VAMP7 was required for the recruitment of LAT-containing
vesicles to TCR-activation sites13. Moreover, results reported
herein showed that recruitment of VAMP7 to the signalosome
was decreased when GMAP210 was silenced (Fig. 4a, quantiﬁed
in Fig. 4b). These results suggested that GMAP210 might bind
VAMP7-bearing vesicles. We ﬁrst observed that the distribution
of VAMP7 in the Golgi was altered by GMAP210 silencing
(Fig. 5a). The expression of VAMP7 was not altered in these cells
(Supplementary Fig. 5a). Of note, the volume of the Golgi was not
signiﬁcantly modiﬁed suggesting that GMAP210 silencing did not
grossly perturb the Golgi apparatus (Supplementary Fig. 5b). To
directly test our hypothesis we then used a strategy, already
described by others28,48, which consists in attaching GMAP210 to
mitochondria and following the ectopic capture of different car-
goes on mitochondria. Jurkat cells were transfected with a con-
struct encoding a GFP chimeric GMAP210 molecule tagged with
the C-terminal hydrophobic anchor of ActA, which anchors
GMAP210 to mitochondria, or with a construct encoding GFP
tagged the same way as control (GFP-Mit)48. Transfected Jurkat
cells were treated with nocodazole, because previous studies
showed that capture of vesicles by golgins on mitochondria was
more efﬁcient when microtubules were depolymerized28,49. The
ectopic localization of GMAP210 to mitochondria induced the
displacement of VAMP7 to the mitochondria (Fig. 5b). This was
speciﬁc of VAMP7, since no displacement of VAMP3, another
vesicular SNARE that controls TCR17 but not LAT recruitment13
to the immune synapse (Fig. 5b), was observed. Unfortunately, we
could not realize this test in activating conditions to see if TCR
activation increased the binding of GMAP210 to VAMP7-
decorated vesicles. Indeed, this assay requires depolymerization
of microtubules, which alters T-cell activation and LAT trans-
port50. These results strongly support that GMAP210 speciﬁcally
binds VAMP7 “decorated” vesicles.
GMAP210 tethering activity controls vesicular trafﬁc of LAT.
GMAP210 binds the intraﬂagellar protein IFT2035,36 and anchors
IFT20 to the Golgi complex35. We previously showed that IFT20
regulates TCR recycling and LAT recruitment to the immune
synapse51,52. We thus investigated if GMAP210 plays a role in the
localization of IFT20 in T lymphocytes. As already observed in
ciliated cells35, absence of GMAP210 induced a dispersion of
IFT20 from the Golgi (Supplementary Fig. 6a and quantiﬁed in
Ssupplementary Fig. 6b). This dispersion of IFT20 was also
observed in cells overexpressing the IFT20-binding CC2 domain
(amino acids 534–1779) coupled to GFP31 (Fig. 6), suggesting
that, in T lymphocytes, GMAP210 retains IFT20 close/at the
Golgi via its CC2 domain. Anchored to the Golgi membranes by
its C-terminal domain30,32,53, GMAP210 which binds vesicles
through its N-terminus domain33,34,49,54 tethers them to the
Golgi. To investigate the role of this tethering activity, we over-
expressed the N-terminal domain encompassing amino acids
1–375, the C-terminal domain (amino acids 1778–1979) and a
shorter version of GMAP210 that contains both N-term and C-
term domains but lacks most of the coiled-coil domain (Fig. 6a).
As described31, all these constructs were localized to the Golgi
(Fig. 6b). In contrast to the overexpression of CC2, none of them
displaced IFT20 from the Golgi (Fig. 6b, c).
We then studied the effect of the overexpression of the
different GMAP210 constructs on LAT recruitment and phos-
phorylation at the immune synapse. Although CC2 overexpres-
sion induced a dispersion of IFT20 from the Golgi (Fig. 6), it did
neither alter LAT recruitment (Fig. 7a, quantiﬁcation in Fig. 7b)
nor LAT phosphorylation (Supplementary Fig. 7a, quantiﬁed in
Supplementary Fig. 7b) to the immune synapse. These results
suggest that although GMAP210 is involved in the localization of
IFT20 to the Golgi apparatus, its binding activity is not required
for LAT trafﬁcking.
In contrast, overexpression of the N-terminal and C-terminal
domains of GMAP210, as well as the short version of GMAP210
induced a signiﬁcant decrease in LAT recruitment to the immune
synapse (Fig. 7a, quantiﬁcation in Fig. 7b). This was accompanied
by less phosphorylated form of LAT at the immune synapse
(Supplementary Fig. 7a, quantiﬁed in Supplementary Fig. 7b). In
contrast overexpression of the short version of GMAP210, which
inhibits LAT recruitment and phosphorylation at the immune
synapse, did not affect the phosphorylation of ZAP70 at the
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immune synapse (Supplementary Fig. 7c and quantiﬁed in
Supplementary Fig. 7d). Altogether, these results suggest that
the tethering activity of GMAP210 is involved in the delivery of
vesicular LAT to the immune synapse.
Trafﬁc of ectopically expressed LAT to the primary cilium.
GMAP210 was also shown to control trafﬁcking of speciﬁc cargos
to the primary cilium35,37,38. We reasoned that LAT, which is not
expressed in ciliated cells, might follow a transport pathway,
which is used by cargoes speciﬁcally going to the cilium. To test
this hypothesis, we expressed LAT in the mIMCD-3-ciliated cells.
LAT was transported to the cilium where it co-localized with
ARL13B, a marker of the cilium55, demonstrating that the
intraciliary trafﬁcking machinery could take care of the vesicular
transport of LAT (Fig. 8a). This was rather speciﬁc since once
introduced in ciliated cells, the transmembrane protein CD3-ζ,
whose recruitment to the immune synapse does not depend on
GMAP210 (Fig. 3) and VAMP713, was not transported to the
cilium (Fig. 8a). Overexpression of the GMAP210-encoding
constructs described earlier also showed that the tethering activity
of GMAP210 was involved in transport of LAT to the cilium
(Fig. 8b). As observed for the synapse, overexpression of the CC2
domain that binds IFT20 did not block LAT trafﬁcking to the
cilium.
These results show that, when ectopically expressed in ciliated
cells, LAT trafﬁcs to the primary cilium. Moreover, they show
that the tethering activity of GMAP210 to the Golgi controls LAT
delivery to the primary cilium highlighting the similarities
between transport to the immune synapse and to the cilium.
Discussion
We show herein that GMAP210 by tethering vesicles containing
LAT to the Golgi helps their correct delivery to the immune
synapse. By doing so it organizes the formation of LAT-
containing signalosomes involved in T lymphocyte activation
revealing a new molecular player in the formation of the immune
synapse.
Several studies have investigated the cellular function of
GMAP210. In some cells, depletion of GMAP210 has been
reported to cause Golgi fragmentation without defect in secretory
trafﬁcking53,56. This is not the case in human T cells, in which no
defect in the Golgi morphology and volume are observed (Sup-
plementary Fig. 5b). GMAP210 is a long coiled-coil molecule that
binds to the cis-Golgi via its C-terminal domain30–32 and
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captures vesicles through its N-terminal domain34,49,54. Using the
mitochondrial relocation assay, it was shown to capture vesicles
containing Golgi, as well as endoplasmic resident proteins28. We
show herein that it also captures vesicles bearing VAMP7
(Fig. 5b), which is expressed on Golgi membrane in T cells
(Fig. 5a). Concerning the speciﬁcity of vesicular binding of
GMAP210, GMAP210 contains an ALPS motif at its N-terminal
end. This motif does not present a sequence-speciﬁc interaction
site, but rather senses the curvature of the vesicles, preferentially
binding highly curved liposomes (radius < 50 nm) with mono-
unsaturated lipids34. The N-terminal domain of GMAP210 also
contains a sequence-speciﬁc interaction, suggesting that this
golgin can bind two different types of vesicles54. It is worth noting
that the sizes of the vesicles containing both LAT and GMAP210,
found in our study (Fig. 1b, d), are compatible with the size
preference of the GMAP210 ALPS domain. This gives us precious
insights and hypothesis to be tested on the potential lipid com-
position of the LAT-containing vesicles, the cargoes they may
contain and the consequences this composition may have on the
formation of the immune synapse.
Humans with mutations in GMAP210 and GMAP210-
knockout mice die early on from a severe skeletal dysplasia57.
This is associated with a defective trafﬁcking of some cargo
proteins in the early secretory pathway of chondrocytes57,58.
The role of GMAP210 in the early secretory pathway, i.e. both
anterograde and retrograde trafﬁcking has been conﬁrmed in
other cell types59,60. We recently showed that the endocytic
LAT is following a retrograde pathway back to the Golgi
apparatus. This transport pathway which exists at steady state is
increased upon TCR activation and is crucial for LAT transport
to the immune synapse24. These results associated to the data
reported herein suggest the following model (Fig. 9): Upon TCR
activation, LAT is endocytosed and transported through the
retrograde transport pathway to the Golgi. From there, vesicles-
containing LAT and VAMP7 are budding and are captured by
GMAP210 to be delivered back to the immune synapse. This
happens 10–15 min after activation and corresponds to an
active phase of vesicle recruitment45. The Golgi apparatus is
polarized close to the immune synapse, as reported early on61
and showed by electron microscopy43,44,62. Yet, it does not
dock to the immune synapse, as shown by the absence of
GM130, a marker of the Golgi, in the evanescent ﬁeld of the
TIRFM. Thus the long coiled-coil domain of GMAP210,
200–300 nm31, could allow the proximity and docking at the
immune synapse of the LAT/VAMP7-vesicles bound to the N-
terminal domain of GMAP210. This pool of vesicular LAT
delivered in a GMAP210-dependent manner participates to the
formation of LAT signalosomes (Fig. 4a, b).
GMAP210 has also been shown to bind IFT20 in several cell
types including T lymphocytes35,36 and to anchor this protein to
the Golgi35. This intraﬂagellar transport (IFT) protein, which
regulates the assembly of the primary cilium, also regulates traf-
ﬁcking of the TCR51 and LAT52 to the immune synapse. Yet, our
results suggest that the IFT20-binding activity of GMAP210 is not
involved in the vesicular transport of LAT (Fig. 7). Moreover,
whereas IFT20 controls TCR/CD3-ζ recruitment to the immune
synapse51, GMAP210 does not (shown here Fig. 3 and Supple-
mentary Fig. 3 and in ref. 36). Thus, at least some effects of IFT20
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on the formation of the immune synapse formation do not rely
on its binding to GMAP210.
One interesting aspects of our study is that, as reported for
transport to the cilium37, GMAP210 does show some speciﬁcities
for vesicles and cargoes delivered to the immune synapse. Indeed,
GMAP210 silencing does not affect CD3-ζ recruitment to the
immune synapse (Fig. 3), this might be due to the difference in
the “nature” of the vesicles containing CD3-ζ.
We now have to characterize if GMAP210 controls the delivery
of other molecules to the immune synapse but also if other gol-
gins are involved in immune synapse formation.
Although, T lymphocytes are non-ciliated cells, morphological
similarities have been shown between the immune synapse and
the primary cilium63,64. In particular, the central role of con-
trolled vesicular trafﬁcking in signaling by these structures has
been demonstrated65–67. Our results further extend this analogy.
Indeed, we show that LAT, an emblematic signaling molecule of
the immune synapse, is transported to the primary cilium
(Fig. 8a) when ectopically expressed in ciliated cells. Like for the
immune synapse, LAT trafﬁcking to the cilium depends on the
tethering activity of GMAP210 (Fig. 8b). Hence, studying LAT
trafﬁcking to the immune synapse can bring information on
vesicular trafﬁcking to the cilium.
Together, our results reveal a new player and a new mechanism
in transport to-and formation of-the immune synapse that may
also be a key player of cilium generation. These results open a
new ﬁeld of research that may have valuable implications in the
study of ciliopathies and immunodeﬁciencies.
Methods
Cells. Jurkat T cells (validated by SSTR method present 88% of homology with
DSMZ Leibniz ACC 282), JCAM2.5 cells stably expressing the mouse LAT-Streptag
construct25, Jurkat expressing the CD3-ζ-GFP chimera described elsewhere68, and
Raji B (ATCC, CCL-86) cells were cultured at 37 °C 5% CO2 in RPMI 1640
Glutamax (Gibco, 61870-010) supplemented with 10% fetal calf serum (FCS,
Lonza, DE14-801F, lot no. 0SB017) and were passed every 2–3 days at ~0.5 × 106
cells/mL.
Inner medullar collecting duct cells (IMCD3, ATCC CRL-2123), a kind gift
from Alexandre Benmerah (Laboratory of Hereditary Kidney Diseases, Imagine
Institute, Paris, France), were grown in Dulbecco’s modiﬁed Eagle’s medium
DMEM-F12 1:1 (GIBCO, 31331-028) supplemented with 10% FCS for basic cell
culture conditions.
Mononuclear cells were isolated from peripheral blood of healthy donors on a
ﬁcoll density gradient. Buffy coats from healthy donors (both male and female
donors) were obtained from Etablissement Français du Sang (Paris, France) in
accordance with INSERM ethical guidelines. Human total CD4+ isolation kit
(Miltenyi Biotech, 130-096-533) was used for the puriﬁcation of T cells. To obtain
lymphoblastoid effector T cells13, six-well plastic plates were coated overnight
at 4 °C with αCD3 (OKT3 clone, eBioscience, 16-0037-85, 2.5 μg/mL ﬁnal
concentration in 1.3 mL). Wells were washed and 5.4 × 106 puriﬁed primary
human total CD4+ T cells were then plated per well in the presence of soluble anti-
CD28 (LEAF Puriﬁed anti-human CD28 from CD28.2 clone, Biolegend,
BLE302923) at 2.5 μg/mL ﬁnal concentration and recombinant human IL-2
(20 U/mL, Novartis, Basel, Switzerland) in RPMI culture medium supplemented
with 10% FCS, penicillin/streptomycin (100 U/mL, Gibco, 15-140-122), 10 mM
HEPES (Gibco, 15630-080) and 0.05 mM β-mercaptoethanol, (Gibco, 31350-010)
at 37 °C, 5% CO2.
Reagents and antibodies. Recombinant Staphyloccocus Enterotoxin type E (SEE,
Cellgenetech, MBS1112600), Ionomycin (407950; Calbiochem), PMA (Sigma-
Aldrich, 79346) and Poly-L-lysine (Poly-Lys, Sigma-Aldrich, P8920) were used.
For detailed information on dilutions, companies, and reference numbers see
Supplementary Table 1.
APC
Extracellular
Centrosome
Endosomes
Recycling
endosomes
GMAP210
Arf1
VAMP7
LAT
LAT+/VAMP7+
Vesicles
LAT+endocytic
Vesicles
Trans
Golgi
Cis
Golgi
ER
Nucleus
CD4
CD3 CD3TCR
MHC-II
Cytoplasm
Cy
to
pl
as
m
Fig. 9 Graphical abstract: GMAP210 facilitates the delivery of vesicles containing LAT to the immune synapse. Upon TCR triggering, LAT is internalized in
recycling endosomes. This endocytic pool of LAT is “retrotransported” to the Golgi apparatus24, where it meets the vesicular SNARE VAMP7 that is
involved in LAT trafﬁcking13. GMAP210, which binds the Golgi through Arf1, sorts and captures the LAT/VAMP7 vesicles via its N-terminal domain (inset).
The long coiled-coil domain of GMAP210 then brings LAT-containing vesicles close to the immune synapse
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Production of lentiviruses and infection of CD4+ T cells. Non-replicative VSV-g
pseudotyped lentiviral particles were produced by transfecting HEK-293T cells with
Gag, Pol, rev, encoding plasmid (pPAX2), envelop encoding plasmid (pMD2.G) and
either the HA-Tev-LAT construct13 encoded in a pWXLD vector, or short hairpin
RNA (shRNA) sequences encoded in pLKO.1 plasmid: Non-targeting control
shRNA (shC, Sigma-Aldrich, Mission shRNA SHC002), GMAP-210-speciﬁc
shRNA, sh3 (Sigma-Aldrich, Mission shRNA, sequence GCAAAGGAACAA-
GAACTCAAT), and sh8 (Sigma-Aldrich, Mission shRNA, sequence GCAGAA-
GATAGAGAGGCTAAACT). Lentivirus were recovered in supernatant after 2 days
and concentrated. 5 × 106 Jurkat T cells were infected for 24 h, cells infected with
shRNA encoding virus were selected in puromycine (2 µg/mL, InvivoGen, ant-pr)
and used 5 days post infection.
Primary human CD4+ T cells were activated in six-well plates coated with anti-
CD3 (2.5 μg/mL) in the presence of soluble anti-CD28 (2.5 μg/mL) and
recombinant IL-2 (20 U/mL). Concentrated virus was added 36–48 h later. Cells
were washed and then put in fresh medium with IL-2 (20 U/mL) and puromycin
(2.5 μg/mL) 24 h later and used 72 h later.
Plasmids. The plasmid encoding LAT-mCherry and CD3ζ-GFP were reported
previously13,68. Plasmids encoding chimeric molecules GFP-GMAP210, N-term-
GFP, GFP-C-term, N-C-term-GFP, GFP-CC2, GFP-GMAP-Mit, GFP-Mit are
described elsewhere31,48.
Transfection. Jurkat T cells were transfected using the Amaxa Cell Line
Nucleoefector Kit V (Lonza, VCA-1003). To do so, 5 × 106 cells were washed,
resuspended in 100 µL of nucleoefector solution and combined with 5–10 µg of
DNA. Cells were passed into the electroporation cuvettes and then electroporated
(Amaxa program X-005). Cells were then incubated at room temperature for
10 min, recovered and diluted in warmed RPMI supplemented with 10% FCS and
cultured for 24 h at 37 °C, 5% CO2.
To transfect IMCD3, cells were grown to conﬂuence on 12 mm coverslips in 24-
wells plate. Medium was removed and 500 µL of Optimem (GIBCO, 31985-047)
was added. In a ﬁnal volume of 50 µL of Optimem, 2 µL of Lipofectamine 2000
(Invitrogen, 11668019), and 2 µg of DNA were mixed and incubated for 10 min at
room temperature. The mix Lipofectamine/DNA was added and cells were
incubated for 24 h to induce ciliogenesis.
Preparation of lysates from Jurkat or Human CD4+ T lymphoblasts. 1 × 106
cells/mL of Jurkat T-cells or human lymphoblasts were washed three times with
cold PBS and incubated on ice for 20 min in 30 µL ice-cold lysis buffer (50 mM Tris
pH 8, 150 mM NaCl, 1,5 mM MgCl2, 1% Glycerol, 1% TritonX100, 0.5 mM EDTA
pH 8, 5 mM NaF) supplemented with a protease inhibitor cocktail (Sigma-Aldrich,
11873580001). Post-nuclear lysates were obtained by centrifugation at maximum
velocity for 15 min at 4 °C. Laemmli Sample Buffer (BIORAD, 161-0747) and
reducing agent (Thermo Fisher Scientiﬁc, NP0009) were added and samples were
heated at 95 °C for 5 min and kept at −20 °C before immunoblot analysis.
Preparation of LAT-containing membranes. JCAM2.5 LAT-deﬁcient Jurkat cells
(150 × 106) expressing the mouse LAT-StrepTag (LAT-TST) protein25 or non-
transfected JCAM.2.5 were washed, resuspended in RPMI at 100 × 106/mL and
activated with soluble anti-CD3 (125 ng/mL) and anti-CD28 (250 ng/mL) anti-
bodies for different times (0, 5, 15, and 30 min). The activation was stopped by
adding cold PBS and the cells were centrifuged at 1800 × g at 4 °C for 5 min. The
cell pellet was then suspended in homogenization buffer (0.25 M sucrose, 10 mM
Tris–HCl pH 7.4, 1 mM EDTA) supplemented with a EDTA-free protease inhi-
bitor cocktail (Roche, 1123000) and a phosphatase inhibitor cocktail (Thermo
Scientiﬁc, 78420). Cell breakage was induced on ice by 25 successive stokes of a
Dounce homogenizer. The cell suspension was then passed 15 times through a
25GA needle to achieve cell disruption and centrifuged for 5 min at 900 × g at 4 °C
to remove nuclei and unbroken cells. The supernatant was transferred into Ultra-
clear centrifugation tubes (Beckman Coulter) and centrifuged at 65,000 × g for 1 H
at 4 °C in a SW55Ti rotor (Beckman Coulter). The pellet was suspended in 1.2 mL
of homogenization buffer supplemented as before and passed several times through
a 25GA needle to ensure complete resuspension of the membranes. This suspen-
sion was transferred into a new tube and mixed with 1.2 mL of a 60% solution of
Optiprep/iodixanol (Axis-shield) to reach a 30% iodixanol suspension. The Opti-
prep solution was diluted extemporaneously into 0.25M sucrose, 60 mM Tris–HCl
pH 7.4, 6 mM EDTA to prepare 1.3 mL of a 20% solution and 1.2 mL of a 10%
solution. The 20% and the 10% iodixanol solutions were layered successively on top
of the 30% suspension and centrifuged at 350,000 × g for 3 h at 4 °C in a SW55Ti
rotor without brake when stopping. Ten fractions of 490 µl were collected from the
top of the tube. To purify LAT-TST-associated membranes, the third fraction
(fraction 3) was incubated for 90 min at 4 °C on a rotating wheel with pre-washed
Strep-Tactin Sepharose resin in presence of protease and phosphatase inhibitors.
Resin was washed in StrepTag washing buffers (Buffer W: Tris–HCl 100 mM, NaCl
150 mM, EDTA 1mM, pH 8.0) and suspended in RIPA lysis buffer before being
submitted to SDS–PAGE and immunoblot analysis.
Puriﬁcation of LAT-signalosome. Jurkat cells (5 × 106) were resuspended in
200 µl of RPMI medium, and magnetic beads (1 × 107) coated with anti-CD3 and
anti-CD28 (Gibco, 11132D) were added in a volume of 100 µl. Beads were incu-
bated with T cells for the appropriate time at 37 °C. Activation was stopped with
the addition of 500 µl cold PBS, and 80 µl (1/10) of samples were collected as ‘input’
and lysed as described above (‘'Preparation of lysates from Jurkat or human CD4+
T lymphoblasts' section). Bead-cell conjugates were then magnetically restrained,
resuspended in 500 µl of ‘freeze–thaw’ buffer (600 mM KCl, 20 mM Tris, pH 7.4,
and 20% glycerol) supplemented with, EDTA-free Protease Inhibitor Cocktail
Tablet (Roche, 1123000). Samples were submitted to seven cycles of freezing and
thawing. After the ﬁnal cycle, 5 µl benzonase (Novagen, 2733353) was added,
followed by incubation for 20 min at room temperature. Samples were magnetically
restrained to purify the bead-attached proteins and then were washed ﬁve times in
the supplemented ‘freeze–thaw’ buffer described above. Bead-associated proteins
were resuspended in lysis buffer and separated by SDS–PAGE and analyzed by
immunoblot.
Immunoblot analysis. Samples were resolved on NuPage 4–12% Bis–Tris gel
(Thermo Fisher Scientiﬁc, NP0323BOX) and liquid transferred (Thermo Fisher
Scientiﬁc, NP00061) on PVDF membranes (Bio-Rad, 162-0177). After blocking
with TBS 0.05% Tween20 5% BSA for 1 h 30 min on rocking platform shaker,
membranes were incubated overnight at 4 °C with primary antibodies. Membranes
were washed three times with TBS 0.05% Tween and incubated for 40 min in TBS
0.05% Tween on rocking platform shaker with the secondary antibody. Bound
antibodies were revealed using the ClarityTM Western ECL substrate (Bio-Rad,
#170-5061), according to the manufacturers’ directions. The intensity of the bands
was quantiﬁed by densitometry using Image Lab 5.2.1 software (Bio-Rad Labora-
tories) and was expressed as arbitrary units. All original gel images are included in
the Source Data ﬁle.
Coverslips and dishes preparation for immunoﬂuorescence assay. 12mm ø
coverslips (VWR, 631-0666) for ﬁxed cells or ﬂuorodishes (World Precision
Instrument Inc., FD35-100) for live imaging were pre-coated with 0.02% of poly-L-
Lysine for 20 min at room temperature and were washed three times in water
before being dried and kept for maximum 2 days.
Preparation of Jurkat T cells and Raji B cells conjugates. Raji B cells were
washed, resuspended at a concentration of 1 × 106 cells/mL in RPMI without FCS
and labeled with CellTracker™ Blue CMAC dye (10 µM, Thermo Fisher, C2110) for
20 min at 37 °C. Labeling was stopped with RPMI 10% FCS and cells were washed
once and resuspended at 1 × 106 cells/mL. Cells were pulsed with SEE (100 ng/mL)
or left untreated for 30 min at 37 °C before being washed once and resuspended at a
concentration of 1 × 106 cells/mL. 100,000 Raji cells were incubated on coverslips
for 30 min, washed once with warmed PBS and 150,000 Jurkat cells resuspended in
RPMI 10% FCS were added for 30 min. Coverslips were washed once with cold PBS
before ﬁxation.
Mitochondrial capture assay in cells expressing GFP-GMAP-Mit. Jurkat cells
were washed, resuspended at 1 × 106 cells/mL and incubated 4 h with nocodazol
(5 μg/mL) in RPMI containing 10% of FCS at 37 °C. 150,000 Jurkat cells were then
incubated on coverslip for 30 min, washed once with cold PBS and ﬁxed.
Fixed and live TIRF microscopy. Poly-L-Lysine-coated coverslips were left
untreated or coated overnight at 4 °C with αCD3ε αCD28, washed three times and
pre-warmed at 37 °C for 10–15 min. 150,000 Jurkat or primary CD4+ T cells were
incubated on coated coverslips for 15 min at 37 °C before being washed once with
cold PBS and ﬁxed. For live imaging, ﬂuorodishes were coated following this same
protocol. 200,000 Jurkat T cells were plated and images for 491 and 561 channels
were acquired every 3 s.
Fixation. Cells were ﬁxed with 4% paraformaldehyde (Life technologies, FB002) for
15 min at room temperature, washed once in PBS and excess of paraformaldehyde
was quenched for 10 min with PBS 10 mM Glycine (Thermo Fisher Scientiﬁc,
G8898). Coverslips were kept at 4 °C in PBS until permeabilization and staining.
Staining and mounting. Cells were permeabilized for 30 min at room temperature
with PBS 0.2% Bovine Serum Albumin (BSA, Euromedex, 04-100-812) 0.05%
Saponin (Sigma-Aldrich, S4521). Cells were then incubated for 1 h at room tem-
perature with primary antibody, followed by washing three times with PBS 0.2%
BSA 0.05% Saponin and incubated protected from light for 20 min in the same
buffer with spinned secondary antibodies. After washing once with PBS BSA
Saponin, and once with PBS, coverslips were soaked three times in PBS, three times
in water, and mounted on slides.
For regular confocal microscopy, coverslips were mounted with 4–6 µL of
Fluoromount G (SouthernBiotech, 0100-01) on slides (KNITTEL Starfrost) and
dried overnight protected from light before microscope acquisition.
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For TIRF microscopy, following staining, with secondary antibody, coverslips
were soaked in PBS and mounted with 4–6 µL of PBS, sealed with uncolored nail
polish and dried for 15 min before acquisition.
Microscopes and Images analysis. Confocal microscopy was achieved using a
Laser Scanning Confocal microscope (LSM780, Zeiss) from the PICT-IBiSA
@Pasteur Imaging facility at Institut Curie, equipped with 40X or 100X Plan Apo
objectives (numerical apertures, 1.35) and a 1-airy unit pinhole size was used.
Single plane images or Z-stack of images were acquired (pixel size around 70 nm).
TIRF microscopy was performed using an inverted Nikon microscope Ti-E from
the Nikon Imaging Center at Institut Curie-CNRS equipped with a 100X CFI Apo
TIRF objective (numerical aperture of 1.49), 491, 561, and 642 nm lasers, and an
EMCCD 512 Evolve camera (Photometrics, pixel size 0.16 µm). For live experi-
ment, temperature was constantly sustained at 37 °C and one image was acquired
every 3 s. Images were analyzed on Fiji and ImageJ software and compatible scripts
were generated for automated or semi-automated analysis.
Recruitment at the immune synapse and “Mean Cell” creation. Single images
corresponding to the middle planes of conjugates were extracted from Z-stack.
T cells were cropped and oriented in the same way regarding their synapse
(script#1). Obtained T cell images were grouped by condition (shRNA ± SEE) and
ﬂuorescence intensities were normalized by the mean ﬂuorescence intensity (MFI).
Images were then resized to the smallest image size in order to create a normalized
stack of images for each group (script#2). All groups were normalized (size and
intensity) before being compared. Stacks of aligned cells were ﬁnally projected
(averaging method) giving single plane “mean cells” (script#3). Stacks were resized
to obtain a 1-pixel height stack by averaging the ﬂuorescence intensity of the total
height of each image. Projections of the 1-pixel resized stacks were obtained based
on average and standard deviation methods and pixel intensities proﬁles were
performed along projections width (script#4). In order to get a cell-by-cell quan-
tiﬁcation, we also computed an enrichment ratio at the synapse. This enrichment
was deﬁned as the ratio between the total cell ﬂuorescence and the ﬂuorescence in
the synaptic region (rectangle at the synapse representing 20% of the total cell).
(script#3).
Enrichment of P-LAT and P-ZAP70 in Jurkat-Raji conjugates. P-LAT and P-
ZAP70 enrichment at the T cell–APC contact site was quantiﬁed as described
previously13. Brieﬂy, in each cell, the MFI at the IS of P-LAT or P-ZAP70 was
divided by the average of the mean intensities measured in three regions of the
same size at the plasma membrane outside of the IS (IS-to-membrane ratio).
Recruitment of molecules to the immune synapse by TIRFM. Before imaging
cells, TIRFM angle was set up to provide an evanescent ﬁeld of ﬁxed thickness
(<120–150 nm). Illuminated puncta were imaged, and the background was sub-
tracted (50 pixels, rolling ball radius) for each acquired image. Cells were manually
segmented to obtain regions of interest (ROIs) and their areas were measured.
Then, within each ROI, puncta present in the evanescent ﬁeld were deﬁned as
signal intensity maxima detected by using the “Find Maxima…” function, for
which a value of noise tolerance was arbitrarily set according to background from
experiment to experiment (values around 5000 in most experiments). Using this
method allowed the discrimination of maximas coming from clusters (local bright
patches at the plasma membrane or just below in the limit of thickness of the
evanescent ﬁeld) from a homogeneous signal. The number of “maximas” was then
counted for each ROI, giving a cell-by-cell quantiﬁcation of the number of puncta
or density of puncta at or below the plasma membrane.
Colocalization assay on TIRFM images by Pearson coefﬁcient. Illuminated
puncta were imaged, and the background was subtracted (50 pixels, rolling ball
radius) for each acquired image. Cells were manually segmented to obtain regions
of interest (ROIs). Within each ROI, colocalization assays were performed using
the JACoP plugin for ImageJ64 to obtain Pearson coefﬁcient.
Analysis of LAT-GMAP210 colocalization in conjugates. Z-stack (0.4 µm)
images of similarly dimensioned conjugates were chosen. In that z-stack, a ROI
surrounding the GMAP210 staining was deﬁned. Within each ROI, colocalization
assays were performed using the JACoP plugin for ImageJ64 to obtain Pearson
coefﬁcient.
Analysis of Golgi volume in Jurkat cells. Z-stack (0.4 μm z-step) images of T cells
were chosen. Then, ROI surrounding the Golgi was deﬁned for each cell based on
CTR433 staining. Within each ROI, masks based on CTR433 staining, were created
by automatic thresholding. To ﬁnish, Golgi volume was measured using the “3D
Objects Counter” plugin from Fiji.
VAMP7-CTR433 colocalization in GMAP210-depleted cells. Z-stack (0.5 µm)
images of similarly dimensioned Jurkat cells were chosen. In that z-stack, a ROI
surrounding the Golgi was deﬁned based on CTR433 staining. Within each ROI,
masks based on both CTR433 and VAMP7 stainings were created by thresholding.
Automatic colocalization assays were performed with Mander’s overlap coefﬁcient,
using the JACoP plugin for ImageJ64.
Analysis of VAMPs capture in the mitochondria. Z-stack (0.5 µm) images of
similarly dimensioned Jurkat cells were chosen. In that z-stack, cells were manually
segmented to obtain a ROI. In each ROI, masks based on both GFP10 and VAMPs
stainings were created by thresholding. Automatic colocalization assays were
performed with Mander’s overlap coefﬁcient, using the JACoP plugin for ImageJ64.
Analysis of IFT20 displacement in Jurkat cells. Middle planes images from Z-
stack images of Jurkat T cells were chosen. Cells were manually segmented. For
each cell, a Golgi mask was deﬁned using the CTR433 staining. To ﬁnish, IFT20
total ﬂuorescence was measured inside the cell and inside the Golgi region. IFT20
displacement was deﬁned as the ratio of Golgi-associated ﬂuorescence vs. total-
associated ﬂuorescence.
Electron microscopy. Rabbit anti-LAT used at 1:50 (Millipore, 06-807), rabbit
anti-GMAP210 1:80 (Gift from Michel Bornens, Institute Curie, Paris, France),
PAG 1:50 (protein A gold, Utrecht University, the Netherlands), F(ab)2 fragment
goat anti-rabbit 6 nm 1:20 (Aurion). Immunoelectron microscopy on ultrathin
cryosections was performed by the Tokuyasu method69. Sections were examined
on a Tecnai Spirit electron microscope (FEI, Eindhoven, The Netherlands)
equipped with a Quemesa camera (EMSIS GmbH, Münster, Germany). For
immunolabeling on whole-mount vesicles, fraction 3 from suspension in PBS
(from JCAM2.5 LAT-deﬁcient Jurkat cells expressing the mouse LAT-StrepTag)
was deposited on formvar-carbon-coated cooper/palladium grids as described
previously70.
Interleukin-2 secretion and production assay in Jurkat cells. Jurkat T cells and
Raji B cells were washed and resuspended at 1 × 106cells/mL. 100 µL Jurkat cells
and 50 µL of Raji cells were mixed in a 96-well plate, ﬂat bottom (TPP, 92096). 50
µL of SEE at the ﬁnal indicated concentrations were added for 6 h. Supernatants
were recovered and tested for IL-2 by ELISA (BD OptEIA, 555190). Total mRNA
was isolated from cells with NucleoSpin RNA kit (Macherey Nagel, 740-955) and
IL-2 mRNA expression was assessed by quantitative Polymerase Chain Reaction
using Taqman method and IL-2 mRNA targeting primers (Thermo Fisher Scien-
tiﬁc, SM-IL2-Hs00174114_m1 for IL-2 and SM-RPL34-Hs00241560_m1 for the
housekeeping).
Interferon-γ secretion primary CD4+ T cells. Human CD4+ T lymphoblasts
were subjected to gradient centrifugation to remove dead cells. 100,000 cells were
activated either on 96-well plate, ﬂat bottom (TPP, 92096) coated overnight at 4 °C
with αCD3εαCD28 at the indicated concentration or with a soluble combination of
10 ng/mL of PMA and 1 µg/mL of ionomycin. Supernatants were recovered after
6 h and tested for IFN-γ by ELISA (BD OptEIA, 555142).
Flow cytometry. Cells were centrifuged and transferred to conical bottom plate
(Greiner Bio-One, 650101), stained for 20 min in cold PBS with Fixable Violet
Dead Cell Stain Kit (1/4000, Invitrogen, L34955) and washed in FACS Buffer (PBS
0.5% BSA 2mM EDTA). Extracellular staining was performed in FACS buffer for
30 min on ice. For surface marker expression of human cells, antibodies anti-CD28,
anti-TCRα/β, anti-CD3, anti-CD4, and anti-HA were used and are described in
Supplementary Table 1. After staining, cells were washed in FACS buffer and ﬁxed
with Cytoﬁx/Cytoperm (BD Biosciences, 554714).
For intracellular cytometry, cells were washed twice in Perm/Wash buffer (BD,
554723), and incubated for 1 h in ice with anti-LAT or anti-CD45. In the next step,
cells were washed twice with perm/wash followed by staining with the
correspondent secondary antibody (see Supplementary Table 1).
Finally, cells and compensation beads (eBioscience, 01-1111-42) were acquired
with BD FACS Verse and MACS Quant (Miltenyi) ﬂow cytometer and data were
analyzed with FlowJo software.
Statistical analysis. Statistical analysis was performed with GraphPad Prism
7 software. Data were considered statistically signiﬁcant if the p-value obtained was
lower than 0.05. Data were compared with the paired or unpaired Student’s t-tests
for values following a Gaussian distribution with similar variances. For multigroup
comparisons, we applied one-way or two-way ANOVA.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The source data underlying Figs. 1a–c, 2a, c, d, e, g, 3b, d, f, 4a–f, 5a, 5b, 6c and 7b and
Supplementary Figs. 2a, b, 3a, c, 4b, c, 5a, b, 6b, 7a, d, are provided as a Source Data ﬁle.
All other data are included in the supplemental information or available from the authors
upon reasonable requests.
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